Journal of Hepatology

Effectiveness of interferon-alpha therapy in chronic hepatitis C is associated with the amount of interferon-alpha receptor mRNA in the liver
pp. 455-461(7)
Authors: Fukuda R.; Ishimura N.; Kushiyama Y.; Moriyama N.; Ishihara S.; Nagasawa S.; Miyake T.; Niigaki M.; Satoh S.; Sakai S.; Akagi S.; Watanabe M.; Fukumoto S.

Analysis of T-cell receptor V repertoire in liver-infiltrating lymphocytes in chronic hepatitis C
pp. 462-470(9)
Authors: Kashii Y.; Shimizu Y.; Nambu S.; Minemura M.; Okada K.; Higuchi K.; Watanabe A.

Serum interleukin 4 and interleukin 10 levels in patients with chronic hepatitis C virus infection
pp. 471-478(8)
Authors: Reiser M.; Marousis C.G.; Nelson D.R.; Lauer G.; Gonzalez-Peralta R.P.; Davis G.L.; Lau J.Y.N.

Ultrasound-detected abdominal lymphadenopathy in chronic hepatitis C: high frequency and relationship with viremia
pp. 479-483(5)
Authors: Cassani F.; Valentini P.; Cataleta M.; Manotti P.; Francesconi R.; Giostra F.; Ballardini G.; Lenzi M.; Zauli D.; Bianchi F.B.

Distribution of hepatitis C virus genotypes in German patients with chronic hepatitis C: correlation with clinical and virological parameters
pp. 484-491(8)
Authors: Berg T.; Hopf U.; Stark K.; Baumgarten R.; Lobeck H.; Schreier E.

The clinical value of grading and staging scores for predicting a long-term response and evaluating the efficacy of interferon therapy in chronic hepatitis C
pp. 492-497(6)
Authors: Shindo M.; Arai K.; Okuno T.

Clinical presentation of GB-C virus infection in drug abusers with chronic hepatitis C
pp. 498-502(5)
Authors: Goeser T.; Seipp S.; Wahl R.; Muller H.M.; Stremmel W.; Theilmann L.

HLA-DRB1*1301 AND *1302 protect against chronic hepatitis B
pp. 503-507(5)
Authors: Hohler T.; Gerken G.; Notghi A.; Lubjuhn R.; Taheri H.; Protzer U.; Lohr H.F.; Schneider P.M.; Meyer zum Buschenfelde K.-H.; Rittner C.

High degree of conservation in the hepatitis B virus core gene during the immune tolerant phase in perinatally acquired chronic hepatitis B virus infection
pp. 508-516(9)
Authors: Bozkaya H.; Akarca U.S.; Ayola B.; Lok A.S.F.

De novo and apparent de novo hepatitis B virus infection after liver transplantation
pp. 517-526(10)
Authors: Roche B.; Samuel D.; Gigou M.; Feray C.; Virot V.; Schmets L.; David M.F.; Arulnaden J.L.; Bismuth A.; Reynes M.; Bismuth H.

Preferential V3 usage by hepatic T lymphocytes in patients with primary sclerosing cholangitis
pp. 527-534(8)
Authors: Bromme U.; Grunewald J.; Scheynius A.; Olerup O.; Hultcrantz R.

The apoptosis protector, bcl-2 protein, is downregulated in bile duct epithelial cells of human liver allografts
pp. 535-542(8)
Authors: Gapany C.; Ming Z.; Arthur Z.

The plasma membrane polarity of human biliary epithelial cells: in situ immunohistochemical analysis and functional implications
pp. 543-553(11)
Authors: Scoazec J.-Y.; Bringuier A.-F.; Medina J.F.; Martinez-Anso E.; Veissiere D.; Feldmann G.; Housset C.

Hypercoagulability in patients with primary biliary cirrhosis and primary sclerosing cholangitis evaluated by thrombelastography
pp. 554-559(6)
Authors: Ben-Ari Z.; Panagou M.; Patch D.; Bates S.; Osman E.; Pasi J.; Burroughs A.

Efficacy of ursodeoxycholic acid treatment and endoscopic dilation of major duct stenoses in primary sclerosing cholangitis - An 8-year prospective study
pp. 560-566(7)
Authors: Stiehl A.; Rudolph G.; Sauer P.; Benz C.; Stremmel W.; Walker S.; Theilmann L.

Decreased endotoxin-binding capacity of whole blood in patients with alcoholic liver disease
pp. 567-573(7)
Authors: Schafer C.; Greiner B.; Landig J.; Feil E.; Schutz E.T.; Bode J.C.; Bode C.

Circulating matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 as serum markers of fibrosis in patients with chronic hepatitis C - Relationship to interferon reponse
pp. 574-583(10)
Authors: Kasahara A.; Hayashi N.; Mochizuki K.; Oshita M.; Katayama K.; Kato M.; Masuzawa M.; Yoshihara H.; Naito M.; Miyamoto T.; Inoue A.; Asai A.; Hijioka T.; Fusamoto H.; Kamada T.

Hepatic stellate cell activation in genetic haemochromatosis - Lobular distribution, effect of increasing hepatic iron and response to phlebotomy
pp. 584-592(9)
Authors: Ramm G.A.; Crawford D.H.G.; Powell L.W.; Walker N.I.; Fletcher L.M.; Halliday J.W.

In situ detection of matrix metalloproteinase-2 (MMP2) and the metalloproteinase inhibitor TIMP2 transcripts in human primary hepatocellular carcinoma and in liver metastasis
pp. 593-605(13)
Authors: Musso O.; Theret N.; Campion J.P.; Turlin B.; Milani S.; Grappone C.; Clement B.

Glutathione kinetics in normal man and in patients with liver cirrhosis
pp. 606-613(8)
Authors: Bianchi G.; Bugianesi E.; Ronchi M.; Fabbri A.; Zoli M.; Marchesini G.

Diuretic requirements after therapeutic paracentesis in non-azotemic patients with cirrhosis. A randomized double-blind trials of spironolactone versus placebo
pp. 614-620(7)
Authors: Fernandez-Esparrach G.; Guevarra M.; Sort P.; Pardo A.; Jimenez W.; Gines P.; Planas R.; Lebrec D.; Geuvel A.; Elewaut A.; Adler M.; Arroyo V.

Time profile of the haemodynamic effects of terlipressin in portal hypertension
pp. 621-627(7)
Authors: Escorsell A.; Bandi J.C.; Moitinho E.; Feu F.; Garcia-Pagan J.C.; Bosch J.; Rodes J.

Acute effects of propylthiouracil on hemodynamics and oxygen content in patients with alcoholic cirrhosis
pp. 628-633(6)
Authors: Sogni P.; Hadengue A.; Moreau R.; Moine O.L.; Soupison T.; Oberti F.; Farinotti R.; Lebrec D.

Autonomic neuropathy in extra-hepatic portal vein thrombosis: evidence for impaired autonomic reflex arc
pp. 634-641(8)
Authors: Voigt M.D.; Trey G.; Levitt N.S.; Raine R.; Lombard C.J.; Robson S.C.; Gordon G.; Kirsch R.E.

Prognostic evaluation of patients with parenchymal cirrhosis - Proposal of a new simple score
pp. 642-649(8)
Authors: Adler M.; Verset D.; Bouhdid H.; Bourgeois N.; Gulbis B.; Le Moine O.; Van de Stadt J.; Gelin M.; Thiry P.

Iron may induce both DNA synthesis and repair in rat hepatocytes stimulated by EGF/pyruvate
pp. 650-658(9)
Authors: Chenoufi N.; Loreal O.; Drenou B.; Cariou S.; Hubert N.; Leroyer P.; Brissot P.; Lescoat G.

Hepatic expression of regeneration marker genes following partial hepatectomy in the rat - Influence of 1,25-dihydroxyvitamin D₃ in hypocalcemia
pp. 659-668(10)
Authors: Goupil D.; Ethier C.; Zarnegar R.; Gascon-Barre M.

Effects of vitamins E, C and catalase on bromobenzene- and hydrogen peroxide-induced intracellular oxidation and DNA single-strand breakage in Hep G₂ cells
pp. 669-677(9)
Authors: WU J.; Karlsson K.; Danielsson .

Endothelial calcium-calmodulin dependent nitric oxide synthase in the in vitro vascular hyporeactivity of portal hypertensive rats
pp. 678-686(9)
Authors: Gadano A.C.; Sogni P.; Yang S.; Cailmail S.; Moreau R.; Nepveux P.; Couturier D.; Lebrec D.

Aminoguanidine corrects hyperdynamic circulation without ameliorating portal hypertension and portal hypertensive gastropathy in anesthetized portal hypertensive rats
pp. 687-693(7)
Authors: Lee F.-Y.; Suh-Sang W.; Yang-Te T.; Hwai-Jeng L.; Han-Chieh L.; Chi-Jen C.; Shwu-Ling W.; Chung-Ching T.; Shou-Dong L.

Adaptive regulation of hepatic bile salt transport: role of bile salt hydrophobicity and microtubule-dependent vesicular pathway
pp. 694-702(9)
Authors: Arrese M.; Pizarro M.; Solis N.; Accatino L.

Monitoring cholesterol crystallization from lithogenic model bile by time-lapse density gradient ultracentrifugation
pp. 703-710(8)
Authors: Konikiff F.M.; Laufer H.; Messer G.; Gilat T.

Inducing cholesterol precipitation from pig bile with -cyclodextrin and cholesterol dietary supplementation
pp. 711-721(11)
Authors: Juste C.; Catala I.; Riottot M.; Andre M.; Parquet M.; Lyan B.; Beguet F.; Ferezou-Viala J.; Serougne C.; Domingo N.; Lutton C.; Lafont H.; Corring T.

Subfulminant syncytial giant cell hepatitis: recurrence after liver transplantation treated with ribavirin
pp. 722-726(5)
Authors: Durand F.; Degott C.; Sauvanet A.; Molas G.; Sicot C.; Marcellin P.; Belghiti J.; Erlinger; Benhamou J.-P.; Bernuau J.

Intrahepatic bile duct injury and nodular regenerative hyperplasia of the liver in a patient with polyarteritis nodosa
pp. 727-730(4)
Authors: Goritsas C.P.; Repanti M.; Papadaki E.; Lazarou N.; Andonopoulos A.P.

Membranous obstruction of the inferior vena cava in a patient with factor V Leiden: evidence for a post-thrombotic aetiology
pp. 731-735(5)
Authors: Blanshard C.; Doge G.; Pasi J.; Ormiston M.; Dick R.; Burroughs A.K.

Images of Hepatology
pp. 736-736(1)

Prevalence of familial disease in primary biliary cirrhosis in Italy
pp. 737-738(2)
Authors: Floreani A.; Naccarato R.; Chiaramonte M.

Lack of epidemiological evidence for a link between thyroid auto-immune disease and hepatitis C virus infection
pp. 738-739(2)
Authors: Gorez E.; Nakib I.; Larbre H.; Schneider N.; Schvartz C.; Delisle M.J.; Delemer B.; Caron J.; Thiefin G.

Acute liver injury due to loracarbef
pp. 739-740(2)
Authors: Bjornsson E.; Olsson R.